Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
4DMedical Ltd ( (AU:4DX) ) has shared an announcement.
4DMedical Limited announced the withdrawal of Resolution 8 from its upcoming Annual General Meeting agenda due to the ASX not granting a waiver from Listing Rule 7.5.4. This resolution involved ratifying a prior agreement to issue shares to Pro Medicus Limited. The withdrawal will not affect the validity of proxy forms already submitted for other resolutions at the AGM. This decision reflects the company’s adherence to regulatory requirements and may impact its strategic financial arrangements.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is a global medical technology company focused on revolutionizing respiratory care through advanced imaging and artificial intelligence. The company offers a range of software solutions, including the FDA-cleared XV Lung Ventilation Analysis Software and the CT:VQ solution, which enhance cardiothoracic imaging by integrating ventilation and perfusion analysis. These solutions are delivered through a Software-as-a-Service model, integrating seamlessly into existing hospital infrastructure to improve physician productivity and patient care. The company’s recent acquisition of Imbio has further advanced its AI capabilities, pushing the boundaries of medical imaging in the understanding and treatment of respiratory diseases worldwide.
Average Trading Volume: 8,320,417
Technical Sentiment Signal: Buy
Current Market Cap: A$972.1M
See more data about 4DX stock on TipRanks’ Stock Analysis page.